Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000670937 | SCV000795859 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2B | 2017-11-21 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001784267 | SCV002021877 | pathogenic | not provided | 2022-11-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002531269 | SCV003524649 | pathogenic | Qualitative or quantitative defects of dysferlin | 2024-02-14 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu266Phefs*6) in the DYSF gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DYSF are known to be pathogenic (PMID: 17698709, 20301480). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with DYSF-related conditions (PMID: 17897828, 33250842, 33610434). This variant is also known as g.794_795delCT (Thr265fsX271); p.Leu298fs. ClinVar contains an entry for this variant (Variation ID: 555171). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003465503 | SCV004194580 | pathogenic | Miyoshi muscular dystrophy 1 | 2021-11-10 | criteria provided, single submitter | clinical testing |